Inhalify

Company Overview

Snapshot

Founded in March 2025 by Hanna Keller, Inhalify operates with 1–10 employees. The company has secured $83,000 in total capital across 3 funding rounds. In February 2025, Inhalify secured a grant, highlighting its ongoing development in pediatric digital health solutions.

Business overview

Inhalify develops a pediatric digital health solution focused on monitoring and supporting inhaler use in children, particularly those under ten who use spacers. The core technology involves a sensor-based add-on device for standard inhalers and spacers, a mobile application for caregivers, and a clinician dashboard. This system uses sensors to verify proper inhalation technique and provides real-time feedback. Data is transferred to the mobile app for adherence tracking and patterns, with a connected interface for clinicians to monitor progress and predict asthma attacks using an AI algorithm. Inhalify addresses the lack of monitoring tools for spacer-based inhaler usage in pediatric respiratory care and is pursuing FDA 510k clearance, serving the Health Tech & Life Sciences sector.

Company Intelligence Q&A

What is Inhalify's primary focus?

Inhalify is developing a pediatric digital health solution designed to monitor and support the correct use of inhalers among children, especially those under ten who utilize spacers.

When was Inhalify founded?

Inhalify was founded in March 2025 by Hanna Keller.

What is the total capital raised by Inhalify to date?

Inhalify has raised a total of $83,000 across 3 funding rounds.

What is Inhalify's regulatory status?

Inhalify is undergoing regulatory planning and intends to pursue the 510k FDA track for its smart asthma inhaler device.

What was a key funding event for Inhalify in 2024?

In August 2024, Inhalify received a grant that included an investment of $9,000 from Road2.